A phase II trial of to determine the anti-inflammatory effects of RPL 554 in healthy volunteers.

Trial Profile

A phase II trial of to determine the anti-inflammatory effects of RPL 554 in healthy volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Sep 2013

At a glance

  • Drugs RPL 554 (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Sponsors Verona Pharma
  • Most Recent Events

    • 09 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
    • 09 Sep 2013 Status changed from recruiting to completed.
    • 10 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top